Navigating Through the Complex Compliance Landscape of Device Performance Study Under IVDR in the Context of an EU Clinical Trial
- Dependence on the status of the associated drug study
- Patient-centric considerations
- Study sponsorship obligations and oversight responsibilities
- Alignment of all entities involved in the Performance Study ecosystem